Pulmonary Hypertension I Flashcards

1
Q

Define Pulmonary Hypertension

A

Narrowing of pulmonary arteries (increased vasocon), right ventricular hypertrophy (due to backflow pressure into right ventricle) = high BP of pulmonary artery in the lungs

image

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What can Pulmonary Hypertension lead to?

A

can lead to right heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is a Right Heart Catheterisation and why is it done? (4)

A

-BP measured through cuffs - in GP’s or at home
-Cannot measure the BP in lungs like this so
-Right Heart Catheterisation is required to confirm the diagnosis of PAH
- not done routinely: need to put in a catheter in femoral/jugular vein to feed it into pulmonary artery (minimally invasive - but still invasive) = not many diagnoses of PAH since it is diff to carry out

image

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is PAH defined by? (2)

A

meanPAP =/greater than 25mmHG at rest
PCWP =/less than 15mmHg

(changes in america)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Vascular Remodelling in PH + underlying causes (5)

A
  • PH is characterised by sustained vasoconstriction and a progressive obliteration of small resistance pulmonary arteries and arterioles
  • Medial thickening, intimal fibrosis and the formation of (concentric remodelling - area of wall has equal thickness) or angioproliferative
    (plexiform) lesions

Plexiform =type 1 PAH/classic lesion

  • Inflammation and endothelial dysfunction and pulmonary artery endothelial cell apoptosis/dysfunction are thought to play an important early role in disease pathogenesis
  • Subsequent proliferation and migration of medial cells including smooth muscle cells, fibroblasts and PA-EC drives the pulmonary vascular remodelling

image

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pulmonary Hypertension causes (8)

A
  • ≥ 25 mmHg [mean pulmonary arterial pressure (PAP), normal 14 +/- 3 mmHg]
  • Genetic predisposition
  • Drugs
  • Heart diseases e.g. aortic valve disease, LHF, mitral valve disease
  • Liver diseases, rheumatic disorders, lung conditions e.g. COPD, pulmonary fibrosis
  • Thromboembolic disease
  • High altitude living (low oxygen conditions)
    -PH found in multiple clinical conditions – clinically classified into 5 groups
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How many types of PAH? - WHO classification (5)

A

5 groups
1) Pulmonary Arterial Hypertension PAH
- idiopathic
-heritable
-drugs + toxins
- HIV etc.
-newborn
1) Pulmonary veno-occulsive disease and/or pulmonary capillary haemangiomatosis
2) Pulmory HT due to LH disease
3) PHT due to lung diseases and or/hypoxaemia
4) Chronic thromboembolic PHT
5) P HT w/unclear and/or multifactorial mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Group 1 PAH (5)

A
  • Rare disorder (15-20 cases per million)
  • Heritable accounts for 15-20% of cases
    – mutations in bone morphogenetic protein (BMPR-II), a receptor for the (TGF)-β superfamily
    – Leads to abnormal growth responses to TGF-β
  • 2-4 times more common in women (esp younger women)
  • Mean age of onset 45 y
  • Prevalence higher in at risk groups (HIV, sickle cell, parasitic infections [developing world])
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Vascular remodelling in PAH from healthy to PAH (3)

A

image

(-chronic vasocon
-prolif + apoptosis
-Migration + ECM synth
-Disturbed metabolism
-Endothelial Dysfun
-in-situ thrombosis
-inflam)

basically dysreg of vascular tone = imbalance of vasocons’s + dilators , abnormal prolif (upreg of genes), and hypoxia-induced vasomotion + remodelling (because reduced lumen = red o2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Growth factor signalling in PAH (3)

A

image

PDGF + FGF - activate tyrosine kinase r = PI3K = PKB Akt cascade
(basically transcription + genes activated that affect cellular processes)
= increased PROLIFERATION, SURVIVAL + MIGRATION caused

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Inflammation-mediated vascular remodelling in PAH (3)

A

image

1) infection/inflammation = cytokine release
2) = Activation of immune cells
3) immune cell infiltration(e.g. macrophages, monocytes, T cells) in vessel wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Group 3 PH (4)

A

Chronic lung disease can lead to prolonged exposure to alveolar hypoxia

due to lung diseases and hypoxia/hypoxaemia (response to this)

Remodelling of pulmonary vasculature
=
Increased pulmonary arterial pressure and right ventricular hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HIF – hypoxia inducible factor (5)

A

mediates the hypoxic response

– TF regulates hypoxia induced gene transcription

– heterodimer, HIF-1α and HIF-1β subunits

– HIF-2α (isoform) - so 1a or 2a can bind to 1b

– HIF-1/2α levels are tightly regulated by O2 and are degraded in normoxia, but stabilised in hypoxia

image

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

HIF subunits binding domains (4)

A

image

bHLH= basic helix loop helix
PAS = per-arnt-sim
TAD= transactivation domain C-terminus or N-terminus
ODD= oxidation dependent degradation domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

KEY SLIDE: HIF-1 regulation by postranslational modification in normoxia + hypoxia (4)

A

Normoxia
1) 3 proline hydroxylase enzymes (PHDs) in the presence of O2 and cofactors hydroxylate HIF-1apha
2) Recognition by von Hippel Lindau (VHL) protein – an E3 ligase which targets HIF for degradation via ubiquitination

Hypoxia – PHDs inactive, HIF translocates to nucleus
= Activates genes involved in angiogenesis, cell migration and metabolism

image

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HIF protein is activated by growth factors (6)

A
  • Growth factor mediated pathways e.g. insulin, IGF-1, PDGF increase HIF protein synthesis in normoxia
  • Receptor tyrosine kinase signalling increased
  • PI3K/AKT/mTOR pathway
  • Ras/MEK/ERK pathway
  • mTOR: mammalian target of rapamycin (if inhib = red PS+T of other genes)
  • PI3K: phosphoinositide 3 kinase
  • AKT: Protein kinase B
  • ERK : extracellular regulated kinase/MAPK: mitogen activated protein kinase

image

17
Q

HIF target genes expressed in pulmonary arterial smooth muscle cells in PH (6)

A

END1 = contraction
KCNA5/KCNB1= increased K+
TRPC1/TRPC6 = increased Ca2+
NHE1 = increased pH
PDK1= glycolysis

18
Q

Hypoxia and PH (3)

A

image

chronic continuous hypoxia

HIF expressed mostly on endo cells (intima) = HIF-2a = EDN1 = HYPERTROPHY, HYPERPLASIA, CONTRACTION